Ibutilide is the only Food and Drug Administration-approved intravenous drug for the rapid termination of atrial fibrillation and flutter. Its mechanism of action is undecided. The drug has been ...
Imricor Medical Systems has conducted its first cardiac atrial flutter ablation in the brand-new purpose built iCMR lab at the Lausanne University Hospital in Switzerland. Special Report ...
U.S. FDA Approves AOP Health’s RapiblykTM (landiolol) for Atrial Fibrillation and Atrial Flutter in the Critical Care Setting AOP Orphan Pharmaceuticals GmbH (AOP Health), based in Vienna ...
Arrhythmias due to digitalis intoxication. Aberrant impulses, abnormal rhythms due to escape mechanisms. Atrial flutter; digitalize first. Incomplete AV block. Marginally compensated ...